|
Originally published In Press as doi:10.1074/jbc.M203425200 on August 2, 2002
J. Biol. Chem., Vol. 277, Issue 43, 40342-40351, October 25, 2002
Pain Perception in Mice Lacking the 3 Subunit of
Voltage-activated Calcium Channels*
Manabu
Murakami §,
Bernd
Fleischmann¶,
Carmen
De
Felipe ,
Marc
Freichel ,
Claudia
Trost ,
Andreas
Ludwig**,
Ulrich
Wissenbach ,
Herbert
Schwegler ,
Franz
Hofmann**,
Jürgen
Hescheler¶,
Veit
Flockerzi , and
Adolfo
Cavalié §§
From the Pharmakologie und Toxikologie,
Universität des Saarlandes, D-66421 Homburg, Germany,
§ Molecular Pharmacology, Tohoku University School of
Medicine, Sendai 980, Japan, ¶ Institut für
Neurophysiologie, Universität zu Köln, D-50931 Köln,
Germany, Instituto de Neurosciencias, Universidad Miguel
Hernandez, 03550 San Juan de Alicante, Spain, ** Institut
für Pharmakologie und Toxikologie, TU München, D-80802
München, Germany,  Institut für
Anatomie, Universität Magdeburg, D-39120 Magdeburg, Germany
Received for publication, April 9, 2002, and in revised form, July 30, 2002
 |
ABSTRACT |
The importance of voltage-activated calcium
channels in pain processing has been suggested by the spinal
antinociceptive action of blockers of N- and P/Q-type calcium channels
as well as by gene targeting of the 1B subunit (N-type). The
accessory 3 subunits of calcium channels are preferentially
associated with the 1B subunit in neurones. Here we show that
deletion of the 3 subunit by gene targeting affects strongly the
pain processing of mutant mice. We pinpoint this defect in the
pain-related behavior and ascending pain pathways of the spinal cord
in vivo and at the level of calcium channel currents and
proteins in single dorsal root ganglion neurones in vitro.
The pain induced by chemical inflammation is preferentially damped by
deletion of 3 subunits, whereas responses to acute thermal and
mechanical harmful stimuli are reduced moderately or not at all,
respectively. The defect results in a weak wind-up of spinal cord
activity during intense afferent nerve stimulation. The molecular
mechanism responsible for the phenotype was traced to low expression of
N-type calcium channels ( 1B) and functional alterations of calcium
channel currents in neurones projecting to the spinal cord.
 |
INTRODUCTION |
Voltage-activated calcium channels represent a family of ionic
channels that play a crucial role in the nervous system by controlling
membrane excitability and neurotransmitter release. Neurones express
L-, N-, P/Q-, and R-type calcium channels, which are composed of the
pore-forming subunit 1 and the accessory subunits , 2 , (1,
2) and probably (3). The importance of 1D (L-type), 1B
(N-type), 1A (P/Q-type), and 1E (probably R-type) for the
function of the nervous system in vivo is underlined by
recent studies with genetically engineered mice (4). By contrast, the
in vivo function of the four known subunits ( 1, 2,
3, 4) of calcium channels is less understood. In heterologous expression systems, subunits are required for the functional expression of 1 subunits (5-7), enhance the current density, and
shift the voltage dependence of the activation and inactivation of
recombinant calcium channels (8-11). Additionally, subunits have
been implicated in the modulation of calcium channels by G proteins
(12-14). In vivo, the expression of subunits is
modified in pathological states such as cardiac dysfunction (15) and diabetes (16). A natural occurring mutation of 4 is associated with
ataxia and absence seizures in lethargic (lh/lh) mice, and this
mutation modifies N- and P/Q-type calcium channels in the brain (17).
The targeted disruption of 1 is lethal (18). In sympathetic neurones
of 3-deficient mice, N- and L-type calcium channel currents are
reduced, the activation of P/Q type calcium channels is altered, and no
difference appears concerning inhibitory effects of norepinephrine on
calcium channel currents (19). Such alterations of calcium channel
currents in sympathetic neurones might be related to the cardiovascular
phenotype of mice lacking the 3 subunit (20). Yet, the in
vivo functions of the 3 subunit of voltage-activated calcium
channels are not well established.
As the 1B subunit of N-type calcium channels is primarily associated
with the 3 subunit in neurones (21, 22), an altered neurotransmitter
release at synaptic sites may be expected in the 3-deficient mice.
Specifically, blockade of N-type calcium channels inhibits tachykinin
release from afferent sensory nerves (23). Within the spinal cord,
N-type calcium channels show the highest density in the superficial
laminae (24, 25). Accordingly, deletion of the 1B subunit
(Cav 2.2) (26-28) and intrathecal injection of the N-type
channel blocker, -conotoxin GVIA (29), reduce the behavior
associated with pain in rodents. Furthermore, the 3 subunit might
also associate with 1A subunits to form P/Q-type calcium channels,
which are present in the deeper laminae of the spinal cord (30) and
might be involved in nociceptive processing (29). In the present study,
we examine the possible function of 3 subunits in nociception and
sensory processing using a mouse model in which the 3 subunit has
genetically been deleted. Because dorsal root ganglions
(DRG)1 contain the cell
bodies of afferent sensory fibers and predominantly express N-type
calcium channel currents (31), binding assays, and pharmacological
testing on DRG neurones with the selective marker of N-type channels,
-conotoxin GVIA, were used to determine the expression of 1B in
DRG neurones. We have also explored for changes in the voltage
dependence and G protein modulation of calcium channel currents in
isolated DRG neurones. In vivo, we analyzed the pain-related
behavior and the spinal cord response to an intense and persistent
barrage of afferent nociceptive impulses (wind-up).
 |
EXPERIMENTAL PROCEDURES |
Generation of 3+/ Mice--
The organization of the 3
gene (32) and the targeting vector used to generate null mutations of
the 3 gene are shown in Fig. 1. Linearized targeting constructs were
electroporated into R1 embryonic stem (ES) cells, and the cells were
selected with G418 and ganciclovir. We identified 3 of 470 ES cell
clones with predicted genomic structures for the targeting vector IIMB.
Selected ES cell clones were microinjected into C57BL/6 blastocysts and transferred into the uteri of pseudopregnant recipient females. Two
independent ES cell clones were transmitted through the germ line. Mice
were kept in essentially specific pathogen-free environment.
Construction and Purification of Glutathione-S-transferase
(GST)- 1b Fusion Protein and Generation of the Antibodies against
1b--
Nucleotides 1269-1857 (aa 403-597) of 1b (33) were
amplified by PCR using the forward primer, 5'-cgg gat ccg agt act tgg aag cct act g, and the reverse primer, 5'-cgg aat tct cag cgg atg tag
acg cct t. The amplified cDNA was ligated into the
BamHI/EcoRI sites of pGEX-4T2 (Amersham
Biosciences). The accuracy was confirmed by sequencing both strands.
BL21(DE3) Escherichia coli were transformed with
pGEX-4AT2- 1b, and protein expression was carried out as previously
described (34). A synthetic peptide
(584KNELEGWGQGVYIR597) of 1b (33) was
coupled to keyhole limpet hemocyanin for injection into rabbit 234. Antibody 234 recognizes the GST- 1b fusion protein (Mr ~59,000) and native 1b in brain and
skeletal muscle (Mr ~72,000). It does not
recognize a GST- 1a fusion protein (Mr
~33,000) or native 1a (Mr ~52,000), which
is predominantly expressed in skeletal muscle. Other antibodies have
been described previously (22). Immunoblots were repeated up to six
times. Pooled tissue from up to three animals (brain microsomes) and up
to 20 animals (DRGs) per genotype, respectively, were processed. The
data shown (Fig. 1, D-E) represent independent,
non-stripped, and non-reused blots.
Nociceptive Tests and Rotorod Test--
The test for nociception
were performed as described (35). The tail flick response was evoked by
a light beam (irradiated heat) or by immersing two thirds of the tail
in water at 52 °C. In the hot plate test, mice were placed on a
plate (56 °C), and responses were counted when the mouse first
licked the hind paws and jumped from the plate (cut-off time, 30 and
60s, respectively). Formalin (25 µl; 2% paraformaldehyde in
phosphate-buffered saline) was injected into the plantar surface of the
left hind paw. The time spent licking or biting the injected paw was
recorded as the nociceptive score. Inflammation was induced by
subcutaneous injection of 10 µl of complete Freund's adjuvant (CFA,
0.5 mg/ml Mycobacterium butyricum in paraffin oil and emulsifying
agent) into the plantar surface of the left hind paw under short
anesthesia with diethyl ether. Before and 60 h after the
CFA injection, the animals were placed on a raised grid, and mechanical
thresholds were measured using calibrated von Frey hairs. In the
rotorod test, mice were trained on the rod for 1 min at rest and 5 min at 16 rpm, and 1 min at rest and 5 min at 24 rpm. For the test, mice
were placed on the apparatus facing away from the experimenter and in
the direction opposite to the rotating rod while it was moving at 32 rpm (cut off time 5 min). The tests were performed with adult male
mice. The genotype of the animals was unknown to the investigator
during the tests.
Extracellular Recordings in the Spinal Cord--
Adult male mice
(30-40 g) of both genotypes were used for extracellular unit
recordings. The anesthesia was induced with diethyl ether and
subsequently with pentobarbital (intraperitoneal 0.5 mg/10 g of body
weight). To control the deep of anesthesia, the tail vein was
canulated, and pentobarbital was given in the form of intravenous bolus
(0.05 mg/10 g of body weight) every 20-25 min during the experiment. A
laminectomy was performed to expose the spinal segments Th8-Th10, and
the thoraxic vertebras were fixed with spinal hooks in a stereotaxic
frame. The left sural nerve was exposed and placed on a bipolar
electrode for stimulation (Grass). The experiments were started after a
recovery period of 30-45 min. Extracellular recordings were made with
tungsten microelectrodes of 5 megohms resistance (WPI, Berlin, Germany) contralateral to the stimulated nerve (i.e. in the right
spinal cord). Initially, the microelectrode was placed 350-500 µm
lateral to the median dorsal spinal vein in the spinal segment Th8 and carefully inserted just under the surface. To search for responsive units, the electrode was driven from this zero point deep through the
spinal cord and trains of 50-V pulses (5 ms long) were regularly delivered to the sural nerve. We used a frequency of 0.2 pulses per
second (pps) in this searching phase to prevent wind-up. If the test
pulses did not evoke spikes within driving distances of maximally 250 µm, the electrode was removed and the searching phase was reinitiated
from a new zero point caudal to a previous one. When the test pulses
evoked spikes, we first rule out the contribution of receptive fields
by stimulating mechanically (brush, pinch) the skin of the back and
hind paws on both ipsilateral and contralateral sides of recording.
Because the sural nerve was cut distal to the bipolar electrode,
responsive units were used for further analysis when no response to
cutaneous stimulation was observed. The thresholds were determined with
a series of 12 pulses of amplitudes between 10 V and 100 V (5 ms long,
0.2 pps). The wind-up was finally evoked with 50-V pulses (5 ms long) delivered for 16 s at 1 pps. Data were collected and analyzed using the Chart software for the PowerLab system (ADInstruments).
Isolation of DRG Neurones--
DRGs were obtained from
adult wild type and 3 / mice, and neurons were dissociated by
incubation in the presence of trypsin type I (0.67 mg/ml medium; Sigma)
and collagenase type II (4 mg/ml medium; Biochrom, Berlin, Germany) for
20 min. The cell suspension was centrifuged for 5 min, the supernatant
withdrawn, and Dulbecco's modified Eagle's medium supplemented
by 10% fetal calf serum was added. Isolated neurones were plated onto
poly-L-lysine (Sigma)-coated glass cover slips and kept in
an incubator. Electrophysiological experiments were performed within
4-16 h after dissociation.
Whole Cell Patch Clamp--
For electrophysiological recordings
glass cover slips were placed into a recording chamber and mounted on
an inverted microscope. Cells were perfused with extracellular
solution, and electrophysiological recordings were started after 10 min. DRG neurons were identified based on their typical morphology
using a 40× phase contrast objective. Ba2+ currents
(IBa) from wild type and 3 / DRG neurons were
recorded using standard whole cell recording techniques (36).
IBa was recorded with an EPC-9 amplifier (HEKA). Upon
establishment of the whole cell configuration, series resistance, fast
and slow capacitance components were compensated using the internal
circuit of the EPC-9 amplifier. The currents were leak-subtracted by
applying n/4 correction mode. Data were sampled at 10 kHz and filtered at 3.3 kHz. Data were analyzed off line using the Pulse-Fit (HEKA) software package. For further analysis, current traces were imported into Sigmaplot (Jandel Scientific). For display current traces were
transferred to CorelDraw (Corel Graphics). All patch clamp experiments
were performed at room temperature. Pipettes of 2-3 megohms resistance
were prepared on a DMZ Universal Puller from 1.5 mm borosilicate glass
capillaries (Clark Electromedical Instruments). The composition of the
recording solutions used was the following (in mM):
intracellular solution, CsCl 95, CsSO4 40, tetraethylammonium chloride 20, CaCl2 1, EGTA 10, Mg-ATP 3, Hepes 10 pH 7.3 (CsOH); extracellular solution,
tetraethylammonium hydroxide 135, BaCl2 10, MgCl2 1.2, Hepes 10, pH 7.4 (tetraethylammonium hydroxide).
Conotoxin Binding Assays--
Whole dorsal root ganglions
were isolated and homogenized in 5 volumes of 5 mM
TRIS-HCl, pH 7.4, containing a protease inhibitor mix (0.1 mM phenylmethylsulfonyl fluoride, 1 mM
phenanthroline, 1 mM iodoacetamide, 1 mM
benzamidine, 1 µM pepstatin A, 1 µg/ml antipain, and 1 µg/ml leupeptin). Equilibrium binding of 125I-labeled
-conotoxin GVIA (Amersham Biosciences) in the absence and presence
of 10 nM unlabeled -conotoxin GVIA was performed in
duplicate at a total incubation volume of 500 µl containing 10 µg
of protein. Binding to isolated DRG neurones was performed as follows:
intact neurones were incubated in the presence of 50 pM
125I-labeled -conotoxin GVIA for 2 h and then
washed three times with Dulbecco's modified Eagle's medium containing
0.1% bovine serum albumin. Nonspecific binding measured in the
presence of 200 nM unlabeled -conotoxin GVIA was less
than 20% of total binding. -Conotoxin GVIA binding has been
quantified by non-linear regression analysis using the SPSS
(Statistical Package for Social Sciences) software.
 |
RESULTS |
Targeted Disruption of the 3 Gene--
The 3 gene
(Fig. 1A) was mutated by
replacing part of its exon 3 and the complete exon 4 (32) with a
neomycin resistance gene (neor). Breeding
of heterozygous mice generated 3 homozygous ( 3 / ) mice at the
rate expected from the Mendelian frequency (160 +/+, 307 +/ and 144 / ). The 3 / mice grew normally, lived longer than one year,
were fertile, and had no obvious symptoms. Offspring were genotyped for
the 3 mutation by Southern blot analysis. Wild type and mutant
alleles were indicated by the presence of a 12- and 8-kb
EcoRI fragment, respectively (Fig. 1B). The
deletion of the 3 gene was confirmed by Northern blot analysis (Fig.
1C) and immunoblotting of brain extracts (Fig.
1D). Additionally, we found no significant differences
between wild type and 3 / mice in the expression levels of 1,
2, and 4 proteins in whole brain (Fig. 1D), suggesting
that there was no apparent compensatory increase of the expression of
other subunits. Furthermore, it is likely that 3 subunits are
also expressed in other parts of the nervous system. The DRGs contain
cell bodies of primary afferent sensory fibers, including myelinated A
fibers and unmyelinated C fibers, which project into the spinal cord.
Thus, DRG neurones represent a central component of pain pathways, and
additionally, isolated DRG neurones represent a well known cell system
in studies of neuronal calcium channels (31). Because the expression
pattern of subunits in DRG neurones is not known, we analyzed
extracts of isolated DRGs using specific antibodies. Western blot
analysis detected the 3 protein in DRGs from control animals but not
from 3 / mice (Fig. 1E). These results indicate that
the gene targeting strategy used in the present study results in
suppression of 3 protein expression in the DRGs of the adult animals
that were selected for further experiments. The protein level of the
1, 2, and 4 subunits was very low but detectable (Fig.
1E). As in brain extracts, no significant change in the
expression level of 1, 2, and 4 was apparent in extracts of
DRGs isolated from 3 / mice.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 1.
Targeted disruption of the calcium
channel 3 gene. A, 3 locus.
Organization of exons (filled boxes) and introns
(lines). Targeting vector IIMB (second diagram),
a 1-kb HincII (H) fragment containing part of
exon 3, exon 4, and part of the following intron, was replaced by the
neomycin resistance cassette (neor). The
bottom diagram shows the structure of the homologous
recombination product. E, EcoRI; P,
probe; tk, herpes simplex virus thymidin kinase gene.
B, identification of 3+/+, 3+/ , and 3 / mice
by Southern (DNA) blot analysis. C, Northern blot of total
RNA extracted from whole brain of 3+/+, 3+/ , and 3 /
mice. The blot was hybridized with mouse 3 cDNA sequences
(nucleotides 291-602); lower panel shows hybridization of
the same filter with human -actin cDNA. D and
E, immunoblot analysis of 3 (top), 1, 2,
and 4 (bottom) expression in brain (D) an in
DRGs (E).
|
|
Nociception Is Altered in 3 / Mice--
Because ablation of
3 suppresses the expression of 3 subunits in the brain and
sensory neurones (Fig. 1), it is likely that the deletion of the 3
subunit might have an impact on neuronal functioning in various regions
of the nervous system and, thus, at different levels of pain processing
pathways. It is known that blockers of N-type calcium channels exert
spinal antinociceptive actions (37-39). Additionally, P/Q-type calcium
channels may be also involved in nociceptive processes at the spinal
level (38, 40). Because 3 subunits associate to form N- and P/Q-type
calcium channels (21, 22, 41), the suppression of 3 subunit
expression (Fig. 1) likely produces major defects in the nociceptive
pathway, and therefore, we analyzed the pain-related phenotype of the
3 / mice in behavioral test for thermal, mechanical, and chemical nociception (42). Responses to acute thermal stimuli were studied using
the tail flick (Fig. 2A) and
hot plate tests (Fig. 2B). Tail flick is primarily a spinal
reflex, whereas a substantial supraspinal component, which involves
lifting and licking of the hind paw, is required in the hot plate assay
(35). Tail flick latencies were longer in the 3 / mice both when
the tail was exposed to heat by irradiation and by immersion in water
at 52 °C (Fig. 2A). In the hot plate test, the latencies
for licking were also increased and the delay for escape jumping was
almost doubled in the 3 / mice (Fig. 2B). Thus,
independent of whether spinal or supraspinal components are engaged in
the nociceptive response, the thresholds for thermal stimuli appear to
be higher in the 3 / mice. By contrast, the responses to acute
mechanical stimuli appear to be normal in the 3 / mice since the
mechanical thresholds measured with von Frey filaments were similar to
the thresholds of wild type mice (Fig. 2C; wild type,
8.12 ± 1.6 mN, n = 10; 3 / ,
6.15 ± 0.7 mN, n = 10). To study the role of the 3 subunit in persistent pain, we examine the behavior of 3 / mice employing CFA and formalin. CFA was injected in the foot pad of
the left hind paw and, within 24-60 h, induced swelling in the
injected paw in wild type mice (injected paw, 2.35 ± 0.07 mm,
contralateral side, 2.02 ± 0.07 mm, p < 0.05, n = 10) and 3 / mice (injected paw, 2.47 ± 0.09 mm, contralateral side, 2.17 ± 0.06 mm, p < 0.05, n = 10). The degree of swelling of the injected
paw was similar in both groups of mice. After 60 h, the mechanical
thresholds measured on the ipsilateral injected paw (Fig.
2C; wild type, 1.65 ± 0.4 mN, n = 10;
3 / , 1.40 ± 0.4 mN, n = 10) and on the
contralateral paw (wild type, 5.21 ± 0.5 mN, n = 10; 3 / , 3.87 ± 0.6 mN, n = 10) were
significantly reduced (p < 0.05) in wild type and
3 / mice when comparing them to the respective thresholds
measured before the CFA injection (Fig. 2C; wild type,
8.12 ± 1.6 mN, n = 10; 3 / , 6.15 ± 0.7 mN, n = 10). Thus, CFA induced hyperalgesia on the
ipsilateral and contralateral side of injection in both groups of
animals. However, no difference between wild type and 3 / mice
was detected in the mechanical thresholds measured after CFA induced
swelling. It appears, therefore, that 3 subunits are not critical
for the development of hyperalgesia in the CFA-induced inflammatory
pain. The neurochemical signature of the CFA-induced pain is the
internalization of substance P receptors in laminae I, II-IV of the
spinal cord (43). Considering that N-type calcium channels are
primarily restricted to laminae I-II (24, 25) and P type channels are
localized in deeper laminae (30), it is likely that alterations of
N-type channels in the 3 / mice become more evident in specific
assays of nociception, like the formalin-induced inflammation that is
associated with internalization of substance P receptors in lamina I
(43). Therefore, we examined the responses of the 3 / mice to
chemical stimuli in the formalin test, which is also a well established
model to study central sensitization events at the spinal level after
peripheral inflammatory states (35). Subcutaneous injection of formalin in the hind paw elicits biphasic pain responses in wild type and 3 / mice (Fig. 3A). In
phase 1, formalin stimulates the nociceptors generating acute pain, and
in phase 2 the inflammation induced by formalin elicits persistent
pain. Both, wild type and 3 / mice behaved similarly in phase 1 but the nociceptive behavior during phase 2 was attenuated by 43% in
3 / mice (Fig. 3, A and B). Because the
tests for thermal, chemical, and mechanical nociception measure motor
responses as end point, we examined possible motor/sedative defects in
the 3 / mice. In the rotorod test, the performance of wild type
and 3 / mice were indistinguishable (time on the rod: wild type,
64.62 ± 17.0 s, n = 8; 3 / , 41.86 ± 9.8 s, n = 8), indicating that locomotor functions
are not altered in the 3 / mice, and thus, the behavioral tests
used in the present study delineate the profile of nociception in the
3 / mice. In summary, the 3 / mice showed higher thresholds
for acute thermal stimuli, but the responses to mechanical stimuli were
not altered either before or after induction of inflammatory pain with
CFA. The acute pain induced by formalin was not altered but the
persistent pain observed in phase 2 of the formalin test was markedly
reduced in the 3 / mice.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
Nociceptive responses of wild type (+/+)
and 3-deficient mice
( / ) to thermal and
mechanical stimuli. A, tail flick latency to noxius
heat (heat irradiation, n = 13 for both groups; tail
immersion at 52 °C, n = 14 for both groups).
B, hot plate test at 56 °C (n = 14 for
both groups). C, response to mechanical stimulation with von
Frey hairs before and 60 h after injection of CFA (-CFA
and +CFA, respectively; n = 10 for both
groups). All data are mean ± S.E. and were analyzed by the
Mann-Whitney U test (*, p < 0.05)
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Nociceptive behavior of wild type (+/+)
and 3-deficient mice
( / ) after subcutaneous
injection of formalin into the hind paw. A, time course
of licking and biting behavior. B, total duration of
nociceptive responses during phase 1 and 2. Data are mean ± S.E.
(n = 7 for both groups) and were analyzed by the
Mann-Whitney U test (*, p < 0.05)
|
|
Neuronal Activity in the Spinal Cord of 3-deficient
Mice--
Myelinated A fibers and small diameter, unmyelinated C
fibers project to the spinal cord and form neuronal pathways that
transmit nociceptive information from the peripheral site of injury to the brain. Among the multiple nociceptive pathways, the spinothalamic pathway originates primarily from neurones in the neck of the dorsal
horn and terminates in the ventroposterior and ventrobasal thalamus
(44). Within the spinal cord, L-type calcium channels are present in
the dorsal horn with a density comparable to brain areas. N-type
calcium channels show the highest densities in the superficial laminae
of the spinal cord (24, 25, 30) and P-type calcium channels in the
deeper laminae (30). Because the response to inflammatory pain appears
to be preferentially damped by the deletion of 3 subunits, we
examined in vivo neuronal responses in the spinal cord
evoked by stimulation of peripheral nerves. The neuronal activity was
recorded deep in the spinal segment Th8, where responsive units of the
spinothalamic pathway are expected, and the stimuli were delivered to
the sural nerve of the contralateral side (see "Experimental
Procedures"). Under these conditions, trains of pulses with
amplitudes up to 30 V, which were applied at a frequency of 0.2 pps,
evoked a volley of spikes that lasted less than 100 ms (Fig.
4A). With pulse amplitudes of
at least 50 V, we detected in wild type and 3 / mice at least two
types of responsive units that can be distinguished by the latencies of
the evoked spikes (Fig. 4A, lower panels). The
latencies shorter than 70 ms probably reflect the contribution of A
fibers, whereas longer latencies likely reflect the activation of C
fibers. To compare the thresholds for the activation of responsive
units in wild type and 3 / mice, we analyzed the spinal activity
evoked by pulses with amplitudes between 10 and 100 V. Under the
present experimental conditions, stimuli with amplitudes above 50 V
evoked maximal spinal activity in wild type and 3 / mice (Fig.
4B). The activity evoked in the spinal cord, however,
depends on the frequency of stimulation. During trains of high
frequency pulses, the neuronal activity increases spontaneously, a
phenomenon that is observed in various nociceptive pathways and is
known as wind-up (45). Thus, to examine the wind-up, we selected an
amplitude of 50 V to evoke maximal responses (Fig. 4B) and
applied trains of pulses with this amplitude at frequencies higher than
0.2 pps. In several experiments with wild type mice, a moderate wind-up with a delay of 10-15 s was observed with a frequency of 0.5 pps (not
shown). Therefore, we compared the wind-up in wild type and 3 /
mice at a frequency of 1 pps (Fig. 5). In
experiments with wild type mice, we consistently observed maximal
activity after 5-7 s of repetitive stimulation, which were accounted
for by the increase of spikes with latencies longer than 100 ms (Fig.
5A). Similar wind-up of the spinal cord activity was not
observed in paired experiments with 3 / mice (Fig. 5,
A and B). Thus, this first characterization of
the spinal cord activity in vivo suggests that the
activation thresholds of responsive units appears not to be affected,
but the wind-up is absent in the 3 / mice.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
Neuronal activity in the spinal cord.
Voltage pulses with amplitudes between 10 and 100 V were delivered to
the sural nerve at a frequency of 0.2 pps, and the evoked activity was
recorded in the contralateral spinal segment Th8. A,
representative recordings of spikes (upper panels) produced
by responsive units in experiments with a wild type (+/+) and a
3 / mouse ( / ). Voltage pulses with the indicated amplitudes
were applied at the time points indicated by arrows. The histograms of
spike latencies (lower panels) were compiled from the
responses to trains of 12 pulses with an amplitude of 50 V. B, thresholds of responsive units. The spikes observed
within 300 ms after each voltage pulse were counted and averaged for
trains of 12 pulses (frequency, 0.2 pps; duration, 5 ms). To estimate
the activity evoked by a given pulse amplitude, the averaged number of
spikes of the corresponding train of pulses was normalized to the
maximal value obtained with pulse amplitudes between 10 and 100 V. Each
symbol represents a different experiment (wild type mice, upper
panel, n = 5; 3 / mice, lower
panel, n = 4). Stimuli above 50 V produced maximal
spinal cord activity in wild type and 3 / mice.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 5.
Spinal cord activity during high frequency
stimulation. Pulses of 50 V amplitude that evoked maximal spinal
cord activity (Fig. 4B) were applied at a frequency of 1 pps. A, high frequency stimulation of the responsive units
characterized in Fig. 4A. During a train of 16 pulses
(upper panel), the evoked activity increased rapidly within
the first 5 s (wind-up) and remained elevated up to 16 s in
the experiment with the wild type mouse (+/+, middle panel).
Similar wind-up was not observed in the 3 / mouse ( / ,
lower panel). B, wind-up during high frequency (1 pps) trains of pulses (amplitude, 50 V; duration, 5 ms). The increase
of evoked activity was estimated as the number of spikes, which were
observed within 500 ms after each pulse divided by the number of spikes
evoked by the first pulse. Different symbols represent the mice
characterized in Fig. 4B (wild type mice, left
panel, n = 5; 3 / mice, right
panel, n = 4).
|
|
Calcium Channel Currents in DRG Neurones--
The previous results
pinpoint the nociceptive defects resulting from the deletion of 3
subunits to the spinal level (Figs. 2-5). Because the expression of
1, 2, and 4 subunits appears unaltered in DRG neurones of
3-deficient mice (Fig. 1), the 1A, 1B, 1C, 1D, and 1E
subunits, which have been detected in murine DRG neurones (46), might
be associated either with 1, 2, or 4 subunits in the
3-deficient mice. To determine the functioning of neuronal calcium
channels in the 3-deficient mice, we recorded whole cell barium
currents (IBa) in isolated DRG neurones. Depolarizing voltage steps were applied from holding potentials of 50 and 110
mV, and difference currents were obtained by subtracting the records at
100 mV from the respective traces at 50 mV (Fig. 6). The large variability of DRG neurones
concerning cell size and calcium channel expression (47, 48) precluded,
however, a quantitative analysis of current amplitudes. Another
observation in this series of experiments was that the activation and
inactivation time courses of compound and difference currents were
similar in 3 / DRG neurones and controls (Fig. 6A).
Because the expression of subunits speeds up the activation and
inactivation of recombinant calcium channels (e.g. 10) and
antisense depletion of subunits produces the converse effects in
DRG neurones (49), this observation indicates that 1, 2, or 4
are able to replace 3, at least, in what concerns activation and
inactivation. Additionally, the coexpression of with 1 subunits
shifts the membrane potential required for channel opening to more
hyperpolarized potentials (1, 2). We observed that the peak of the
aggregate whole cell current measured at a holding potential of 110
mV was typically at 10 mV in control and at 0 mV in the 3 /
mutants (Fig. 6A). As can be seen in the normalized
current-voltage relationships obtained at a holding potential of 70
mV (Fig. 6B), the whole cell current activation is shifted
by ~8 mV to more depolarized potential in 3 / neurones when
compared with wild type. The activation midpoints in the normalized
curves of Fig. 6B are 15.4 and 23.5 mV for 3 / and
wild type neurones, respectively. When the current voltage
relationships of the individual neurones were fitted with a Boltzmann
equation as described previously (50), the calculated potentials for
half-activation in 3 / and wild type neurones were 9.1 ± 1.1 mV (n = 17) and 18.1 ± 2.1 mV
(n = 11), respectively. A similar shift in the voltage
dependence of calcium channel currents was observed in sensory neurones
treated with generic anti- -antisense oligonucleotides (50). Because subunits have been implicated in the G protein-mediated inhibition and voltage-dependent facilitation of neuronal calcium
currents (13, 14), an abnormal modulation of whole cell calcium channel current by G proteins is expected in the 3-deficient mice. As previously reported (51, 52), we found that activation of G proteins
with GTP- -S slowed the activation kinetics of calcium channel
currents and reduced the current amplitude in wild type DRG neurones
(Fig. 7A). Depolarizing
prepulses accelerated the activation of whole cell calcium channel
currents, increased the current amplitude and shifted the
current-voltage relationship to more negative potentials (Fig.
7A), in line with the voltage-dependent unblocking of G protein-mediated inhibition of neuronal calcium channels (53, 54). The prepulse facilitation resulted in a voltage-dependent facilitation of calcium channel currents
(Fig. 8A). By contrast, we
found that depolarizing prepulses sped up the activation time course of
whole cell calcium channel currents after dialysis of GTP- -S in the
majority of 3 / DRG neurones (9 of 13), but no increase of
current amplitude was observed, and accordingly, there was no shift in
the current-voltage relationship (Fig. 7B). Thus, the main
difference between this group of 3 / neurones and wild type
neurones is observed in the degree of prepulse facilitation of whole
cell calcium currents (Fig. 8, A and B). This
observation is in line with previous studies, which showed that the
degree of facilitation of recombinant calcium channels is strongly
dependent on the expressed subunit, although the activation time
course of whole cell currents facilitated by a prepulse is similar for
all subunits (55). In the remaining 3 / DRG neurones (4 of
13), GTP- -S had no effect at all and depolarizing prepulses produced
an strong inactivation of calcium channel currents (Fig.
8B). All in all, this first electrophysiological characterization of DRG neurones of 3-deficient mice indicates that
the voltage-dependent facilitation of calcium channel
currents is altered and the voltage dependence of the activation is
shifted to more depolarized potentials, although the time course of
activation and inactivation is apparently normal.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
Voltage dependence of calcium channel
currents in DRG neurones. Whole cell currents (IBa)
were evoked from various holding potentials (HP) with
depolarizing pulses to potentials between 40 and +40 mV in 10-mV
increments. A, representative whole cell current families
from DRG neurones of wild type (left panels, +/+) and
3 / mice (right panels, / ) elicited from the
indicated holding potentials. Difference currents were obtained by
subtracting current traces at HP = 50 mV from the respective
traces at HP = 110 mV. In the wild type neurone, the I-V
relationships obtained with holding potentials of 110 mV
(continuous line) and 50 mV (dotted line) show
peaks of IBa amplitude at 10 mV and 0 mV, respectively.
IBa evoked in the 3 / neurone from both holding
potentials peaked at 0 mV. B, activation of whole cell
currents in response to depolarizing pulses from a holding potential of
70 mV. Current amplitudes were normalized (filled circles,
continuous line: wild type, n = 11;
open circles, dotted line: 3 / neurones,
n = 17). The activation midpoints were 23.5 mV and
15.4 mV for wild type and 3 / neurones, respectively.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 7.
Voltage-dependent facilitation of
calcium channel currents in DRG neurones. After cell dialysis with
GTP- -S (500 µM), whole cell currents were elicited
with test pulses from a holding potential of 70 mV to potentials
between 30 mV and +30 mV. The voltage-dependent
facilitation was induced with a prespulse to +80 mV. Superimposed are
consecutive whole cell current traces obtained without (1)
and with (2) prepulses at the test potentials indicated on
the left (upper panels). The I-V relationships (bottom
panels) show whole cell current amplitudes measured 10 ms after
onset of test pulses without (1, dotted line) and
with prepulse (2, continuous line). The
representative example from a wild tpye DRG neurone (A)
shows the slow activation of calcium channel currents after dialysis
with GTP- -S (1) and the prepulse-dependent
facilitation (2). Prepulses induced also a shift of the I-V
relationship to hyperpolarizing potentials. As illustrated in the
recordings from a 3 / neurone (B), prepulses sped up
the activation of whole cell currents in 3 / DRG neurones but had
almost no effect on the I-V relationship.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 8.
Prepulse facilitation. Summary of
experiments with DRG neurones in the absence (control) and presence of
GTP- -S (500 µM) is shown. Calcium channel current
amplitudes were measured 10 ms (full circles) and 49 ms
(open squares) after the onset of the test pulse.
Facilitation was calculated as the ratio of current amplitudes obtained
with and without the prepulse to +80 mV. A, prepulse
facilitation is seen in wild type neurones at all potentials
(n = 12). B, the majority of 3 /
neurones exhibited almost no prepulse facilitation (middle
panel, n = 9). In an small number of 3 /
neurones (right panel, n = 4), prepulses
induced strong inactivation of whole cell currents (inset;
1, no prepulse; 2, with prepulse;
calibration bars, 20 ms and 500 pA). The values are
mean ± S.E.
|
|
Expression of Calcium Channel 1B Subunits in Dorsal Root
Ganglions--
In murine DRG neurones, 1B, 1A, as well as 1C,
1D, and 1E have been detected with specific antibodies (46).
Considering this wide expression of 1 subunits in DRG neurones, the
deletion of the 3 subunit (Fig. 1) could alter in principle N-,
P/Q-, L- and R-type calcium channels. In sympathetic neurones of
3-deficient mice, N-type calcium channel current densities are
reduced, while P/Q-type current densities appear to be normal (19). At
the synaptic sites in the spinal cord, N-type calcium channels appear to mediate neurotransmitter release (56, 57). As a consequence, 3
deletion could be important for nociception and sensory processing due
to the reduction of N-type calcium channels in DRG neurones, as
indicated by our whole cell current recordings (Fig. 6). Because the
N-type component of calcium currents appears to be variable within the
heterogeneous population of DRG neurones (47, 48), we first analyzed
the expression of 1B in DRG homogenates using binding assays with
125I-labeled -conotoxin GVIA, a N-type channel blocker.
The specific binding estimated with increasing concentrations of
125I-labeled -conotoxin GVIA was reduced by a factor of
~2 in homogenates of 3 / DRG neurones (Fig.
9A). This result suggests that
the expression of 1B is reduced in the mutant. Because subunits control the membrane targeting of 1 subunits, we repeated binding assays with intact neurones to estimate the expression of 1B in the
membrane. As in the experiments with DRG homogenates (Fig. 9A), the specific binding at a saturating concentration of
the N-type blocker was reduced in intact DRG neurones (Fig.
9B), indicating that the number of N-type calcium channels
present in the membrane of DRG neurones is reduced in the
3-deficient mice. Because these observations suggest that the
proportion of N-type currents is reduced in the mutant mice, we
determine the inhibitory effects of -conotoxin GVIA on whole cell
currents of DRG neurones. As reported previously for sympathetic
neurones (19), we observed that the percentage of current inhibition by
-conotoxin GVIA ranges from 37% to 70% in wild type and from 0%
to 68% in 3 / DRG neurones. The cumulative distributions
indicate, however, that the percentage of inhibition is often less than
25% in 3 / DRG neurones (Fig. 9C, lower panel). On
average, the inhibitory effects of -conotoxin GVIA are less
pronounced in 3 / than in wild type DRG neurones (Fig.
9C, upper panel). Thus our binding studies and pharmacological experiments with -conotoxin GVIA imply
that the number of functional N-type calcium channels and, consequently, the proportion of N-type calcium channel currents are
reduced in DRG neurones of 3-deficient mice.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 9.
Binding of
-conotoxin GVIA ( CTX) to
DRG neurones. A, specific CTX binding in homogenates
of dorsal root ganglions from wild type (+/+, full circles)
and 3 / mice ( / , open circles). Apparent
Bmax values are significantly different (+/+: 25.08 fmol/mg
protein (95% confidence interval 0.76-1.27); / : 13.21 fmol/mg protein (95% confidence interval 0.43-0.65)), whereas
KD values do not differ significantly
(KD range 1.1 to 8.9 pM). Experiments
have been performed in duplicate with DRGs isolated from 60 mice.
B, specific CTX binding to intact DRG neurones (~14,400
neurones per determination) isolated from wild type (filled
box, n = 7) and 3 / mice (open
box, n = 6). C, inhibition of whole
cell calcium channel currents by CTX (3 µM) in DRG
neurones. Whole cell currents were elicited by depolarizations (100 ms
long) to 10 mV from a holding potential of 70 mV. The percentage of
inhibition was calculated from peak current amplitudes obtained before
and after (50-100 s) bath application of CTX. Whole cell currents
of 3 / neurones (upper panel, open box,
n = 10) are less susceptible to inhibition by CTX
than wild type neurones (upper panel, filled box,
n = 6). As seen in the cumulative probability plots for
wild type (lower panel, continuous line,
n = 6) and 3 / neurones (lower panel,
dotted line, n = 10), CTX rarely inhibits
whole cell currents of 3 / neurones by more than 25%. The values
represent mean ± S.E., the asterisks indicate
p < 0.05, Student's t test.
|
|
 |
DISCUSSION |
In the present study, we examined the role of the 3 subunit of
calcium channels in the pain perception. The use of a gene-targeting strategy to suppress the expression of 3 subunits allowed the analysis throughout various levels, including protein expression and
calcium channel currents in single DRG neurones, functioning of
neuronal circuits in the spinal cord of anesthetized animals, and
nociceptive behavior in awake mice. Our results show that 3 subunits
are critically involved in the function of nociceptive pathways and,
thus, delineate the in vivo function of one of the so-called
auxiliary subunits of voltage-dependent calcium channels.
In behavioral assays, we studied the thermal, mechanical, and chemical
nociception of the 3 / mice. Responses to acute mechanical and
thermal stimuli were not altered or only moderately increased in the
3 / mice, respectively (Fig. 2). Similarly, the thresholds for
activation of responsive units in the spinothalamic pathway were not
apparently changed in the 3 / mice (Fig. 4). However, the
formalin test, which is based on the measurement of licking/biting time
as a robust predictor for nociception (42), revealed that 3 /
mice develop weak hyperalgesia/allodynia after inflammation because the
nociceptive behavior was strongly damped in the tonic, inflammatory
phase 2 (Fig. 3). In this respect, the response of 3 / mice
compares to the behavior of mice lacking the 1B subunit, which also
develop weak hyperalgesia/allodynia after formalin inflammation
(26-28). This parallel is in accordance with our finding that DRG
neurones of 3 / mice have fewer binding sites for -conotoxin GVIA, a blocker of N-type calcium channels (Fig. 9). Our binding and
pharmacological studies with -conotoxin GVIA (Fig. 9), furthermore, also suggest that the deletion of the 3 subunit reduced the membrane expression of 1B. The contribution of L-type calcium channel currents to the development of formalin-induced hyperalgesia seems unlikely, although our results do not rule out a reduction of L-type
current in DRG neurones of 3 / mice. When L-type blockers are
administered systemically, antinociceptive effects have been observed
in rats using the formalin test (e.g. Ref. 58). However, direct application of L-type blockers to the surface of the spinal cord, which is equivalent to intrathecal injection, has no effect on
the excitability of dorsal horn neurones produced by formalin inflammation in the rat (38). Accordingly, intrathecal injection of
specific blockers of L-type calcium channels has no effect on the
nociceptive behavior of rodents either during the early phase or during
the late phase of the formalin test (29, 39). Unfortunately, a
comparison between the phenotypes of 3-, 1C-, and 1A-deficient
mice is not possible because 1C (Cav 1.2) and 1A
(Cav 2.1) deletion were embryonic lethal and generate
strong neurological deficits, respectively (59, 60). Nevertheless, application of the P-type blocker -agatoxin IVA to the surface of
the spinal cord selectively blocks the excitability of dorsal horn
neurones in phase 2 (38), and accordingly, intrathecal injection of the
P-type blocker reduces the nociceptive behavior during the late phase
but not during the acute phase of the formalin test in the rat (40). On
the other hand, intrathecal injection of the N-type blocker
-conotoxin GVIA reduces the nociceptive behavior in phase 1 and 2 of
the formalin test in mice (39) and rats (29). In the formalin tests
that were repeated independently in three laboratories of the authors,
no clear differences were observed in the behavior of wild type and
3 / mice during the early phase (Fig. 9). Mice deficient in 1B
subunits also behave normally in the phase 1 (26-28). Although the
unaltered phase 1 in 1B- and 3-deficient mice may reflect
compensatory mechanisms, the possibility remains that defects of P-type
calcium channels may account partially for the reduced nociceptive
responses of 3 / mice in the formalin test. We compared the
pain-related behavior of the 3 / mice in formalin and CFA tests,
which are based on inflammatory processes that produce distinct
neurochemical signatures in the spinal cord. The CFA-induced
inflammation produces internalization of substance P receptors in
laminae I, II-IV of the spinal cord, while the formalin-induced
inflammation appears to induced substance P receptor internalization in
lamina I (43). Considering that N-type calcium channels are primarily
restricted to laminae I-II (24, 25) and that P type channels are
localized in deeper laminae (30), our results (Figs. 2 and 3) favor the in vivo importance of a possible modification of spinal
N-type channels by deletion of 3 subunits and underscore the
importance of possible alterations of P-type calcium channels.
Furthermore, deletion of 3 subunits appears to have not much effect
on the expression but alters the voltage-dependent
activation of P/Q-type calcium channels, at least in sympathetic
neurones (19). In the bodies of 3 / DRG neurones, we observed a
depolarizing shift in the voltage dependence of the activation of
compound calcium channels currents (Fig. 6). Thus, deletion of 3
alters the function of calcium channels that are expressed in the
membrane, in way that makes them less sensitive to membrane
depolarization. Additionally, the voltage-dependent
facilitation of compound calcium channel currents (Fig. 7 and 8) and,
likely, the G protein modulation of calcium channels are altered in
3 / DRG neurones. These defects in the activation and G protein
modulation of the expressed calcium channels as well as the low
expression of N-type calcium channels (Fig. 9) likely modify the pain
perception at the spinal level. To support this conclusion, we studied
responsive units in the spinothalamic pathway. In wild type but not in
3 / mice, high frequency stimulation of the sural nerve induced
wind-up, which probably represents sensitization at the spinal level
(Fig. 5). This defect in the processing of pain perception at the
spinal level likely reflects the reduced expression of N-type calcium channels together with altered calcium channel currents induced by the
ablation of 3. By contrast, spinal and supraspinal nociceptive components account for the low sensitivity in the formalin test of mice
lacking the 1E subunit (Cav 2.3) (61).
The importance of calcium channel auxiliary subunits in vivo
is underlined by the role of 2 and subunits in
neuroplasticity after nerve injury (62) and in pathological states such
as cardiac dysfunction (15) and diabetes (16), respectively. The
results of the present study suggest an important in vivo
function of 3 subunits in the nervous system, specifically, in the
pain processing at the level of the spinal cord. It is not known
whether the expression of 3 subunits is affected in pathological
states, but the specific nociceptive action of the deletion of 3
subunits indicates that, like 1B (63) and 2 (64), the 3
subunits are important pharmacological targets for the modulation of
pain in pathological states.
 |
ACKNOWLEDGEMENTS |
We thank Birgit Spohrer for excellent
technical assistance in the in vivo recordings of
neuronal activity, Frank Zimmermann, Angus King, and Peter Wollenberg
for helpful advice and discussions.
 |
FOOTNOTES |
*
This study was supported by grants from the Deutsche
Forschungsgemeinschaft and Fonds der Chemie (to V. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§§
To whom correspondence should be addressed. Tel.:
49-6841-1626151; Fax: 49-6841-1626402; E-mail:
adolfo.cavalie@uniklinik-saarland.de.
Published, JBC Papers in Press, August 2, 2002, DOI 10.1074/jbc.M203425200
 |
ABBREVIATIONS |
The abbreviations used are:
DRG, dorsal root
ganglions;
ES, embryonic stem;
GST, glutathione
S-transferase;
CFA, Freund's adjuvant;
pps, pulses per
second;
N, newton.
 |
REFERENCES |
| 1.
|
Hofmann, F.,
Biel, M.,
and Flockerzi, V.
(1994)
Annu. Rev. Neurosci.
17,
399-418[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Catterall, W. A.
(1995)
Annu. Rev. Biochem.
64,
493-531[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Kang, M. G.,
Chen, C. C.,
Felix, R.,
Letts, V. A.,
Frankel, W. N.,
Mori, Y.,
and Campbell, K. P.
(2001)
J. Biol. Chem.
276,
32917-32924[Abstract/Free Full Text]
|
| 4.
|
Muth, J. N.,
Varadi, G.,
and Schwartz, A.
(2001)
Trends Pharmacol. Science
22,
526-532[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Gurnett, C. A.,
and Campbell, K. P.
(1996)
J. Biol. Chem.
271,
27975-27978[Free Full Text]
|
| 6.
|
Brice, N. L.,
and Dolphin, A. C.
(1999)
J. Physiol. (Lond)
15,
685-694
|
| 7.
|
Bichet, D.,
Cornet, V.,
Geib, S,
Carlier, E.,
Volsen, S.,
Hoshi, T.,
Mori, Y.,
and De Waard, M.
(2000)
Neuron
25,
177-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Mori, Y.,
Friedrich, T.,
Kim, M. S.,
Mikami, A.,
Nakai, J.,
Ruth, P.,
Bosse, E.,
Hofmann, F.,
Flockerzi, V.,
Furuichi, T.,
et al..
(1991)
Nature
350,
398-402[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Hullin, R.,
Singer-Lahat, D.,
Freichel, M.,
Biel, M.,
Dascal, N.,
Hofmann, F.,
and Flockerzi, V.
(1992)
EMBO J.
11,
2033-2038[Medline]
[Order article via Infotrieve]
|
| 10.
|
Welling, A.,
Bosse, E.,
Cavalie, A.,
Bottlender, R.,
Ludwig, A.,
Nastainczyk, W.,
Flockerzi, V.,
and Hofmann, F.
(1993)
J. Physiol.
471,
749-765[Abstract/Free Full Text]
|
| 11.
|
De Waard, M.,
Witcher, D. R.,
Pragnell, M.,
Liu, H.,
and Campbell, K. P.
(1995)
J. Biol. Chem.
270,
12056-12064[Abstract/Free Full Text]
|
| 12.
|
Schneider, T.,
Igelmund, P.,
and Hescheler, J.
(1997)
Trends Pharmacol. Sci.
18,
8-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Dolphin, A. C.
(1998)
J. Physiol. (Lond)
506,
3-11[Free Full Text]
|
| 14.
|
Dascal, N.
(2001)
Trends Endocrinol. Metab.
12,
391-398[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Hullin, R.,
Asmus, F.,
Ludwig, A.,
Hersel, J.,
and Boekstegers, P.
(1999)
Circulation
100,
155-163[Abstract/Free Full Text]
|
| 16.
|
Iwashima, Y.,
Abiko, A.,
Ushikubi, F.,
Hata, A.,
Kaku, K.,
Sano, H.,
and Eto, M.
(2001)
Biochem. Biophys. Res. Commun.
280,
923-932[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Burgess, D. L.,
Biddlecome, G. H.,
McDonough, S. I.,
Diaz, M. E.,
Zilinski, C. A.,
Bean, B. P.,
Campbell, K. P.,
and Noebels, J. L.
(1999)
Mol. Cell. Neurosci.
13,
293-311[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Gregg, R. G.,
Messing, A.,
Strube, C.,
Beurg, M.,
Moss, R.,
Behan, M.,
Sukhareva, M.,
Haynes, S.,
Powell, J. A.,
Coronado, R.,
and Powers, P. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13961-13966[Abstract/Free Full Text]
|
| 19.
|
Namkung, Y.,
Smith, S. M.,
Lee, S. B.,
Skrypnyk, N. V.,
Kim, H.-L.,
Chin, H.,
Scheller, R. H.,
Tsien, R. W.,
and Shin, H.-S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12010-12015[Abstract/Free Full Text]
|
| 20.
|
Murakami, M.,
Yamamura, H.,
Murakami, A.,
Okamura, T.,
Nunoki, K.,
Mitui-Saito, M.,
Muraki, K.,
Hano, T.,
Imaizumi, Y.,
Flockerzi, T.,
and Yanagisawa, T.
(2000)
J. Cardiovasc. Pharmacol.
36,
S69-S73[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Scott, V. E.,
DeWaard, M.,
Liu, H.,
Gurnett, C. A.,
Venzke, D. P.,
Lennon, V. A.,
and Campbell, K. P.
(1996)
J. Biol. Chem.
271,
3207-3212[Abstract/Free Full Text]
|
| 22.
|
Ludwig, A.,
Flockerzi, V.,
and Hofmann, F.
(1997)
J. Neurosci.
17,
1339-1349[Abstract/Free Full Text]
|
| 23.
|
Morimoto, H.,
Matsuda, A.,
Ohori, M.,
and Fujii, T.
(1996)
Jpn. J. Pharmacol.
71,
161-166[Medline]
[Order article via Infotrieve]
|
| 24.
|
Kerr, L. M.,
Filloux, F.,
Olivera, B. M.,
Jackson, H.,
and Wamsley, J. K.
(1988)
Eur. J. Pharmacol.
146,
181-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Gohil, K.,
Bell, J. R.,
Ramachandran, J.,
and Miljanich, G. P.
(1994)
Brain Res.
653,
258-266[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Saegusa, H.,
Kurihara, T.,
Zong, S.,
Kazuno, A.,
Matsuda, Y.,
Nonaka, T.,
Han, W.,
Toriyama, H.,
and Tanabe, T.
(2001)
EMBO J.
15,
2349-2356[CrossRef]
|
| 27.
|
Hatakeyama, S.,
Wakamori, M.,
Ino, M.,
Miyamoto, N.,
Takahashi, E.,
Yoshinaga, T.,
Sawada, K.,
Imoto, K.,
Tanaka, I.,
Yoshizawa, T.,
Nishizawa, Y.,
Mori, Y.,
Niidome, T.,
and Shoji, S.
(2001)
Neuroreport
12,
2423-2427[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Kim, C.,
Jun, K.,
Lee, T,
Kim, S. S.,
McEnery, M. W.,
Chin, H.,
Kim, H. L.,
Park, J. M.,
Kim, D. K,
Jung, S J.,
Kim, J.,
and Shin, H. S.
(2001)
Mol. Cell. Neurosci.
18,
235-245[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Vanegas, H.,
and Schaible, H.
(2000)
Pain
85,
9-18[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Westenbroek, R. E.,
Hoskins, L.,
and Catterall, W. A.
(1998)
J. Neurosci.
18,
6319-6330[Abstract/Free Full Text]
|
| 31.
|
Carbone, E.,
and Lux, H. D.
(1987)
J. Physiol. (Lond)
386,
547-570[Abstract/Free Full Text]
|
| 32.
|
Murakami, M.,
Wissenbach, U.,
and Flockerzi, V.
(1996)
Eur. J. Biochem.
236,
138-143[Medline]
[Order article via Infotrieve]
|
| 33.
|
Pragnell, M.,
Sakamoto, J.,
Jay, S. D.,
and Campbell, K. P.
(1991)
FEBS Lett.
291,
253-258[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Marquart, A.,
and Flockerzi, V.
(1997)
FEBS Lett.
407,
137-140[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
De Felipe, C.,
Herrero, J. F.,
O`Brien, J. A.,
Palmer, J. A.,
Doyle, C. A.,
Smith, A. J. H.,
Laird, J. M. A.,
Belmonte, C.,
Cervero, F.,
and Hunt, S. P.
(1998)
Nature
392,
394-397[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Hamill, O. P.,
Marty, A.,
Neher, E.,
Sakmann, B.,
and Sigworth, F. J.
(1981)
Pflügers Arch.
391,
85-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Malmberg, A. B.,
and Yaksh, T. L.
(1995)
Pain
60,
83-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Diaz, A.,
and Dickenson, A. H.
(1997)
Pain
69,
93-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Murakami, M.,
Nakagawasai, O.,
Fujii, S.,
Kameyama, K.,
Murakami, S.,
Hozumi, S.,
Esashi, A.,
Taniguchi, R.,
Yanagisawa, T.,
Tan-no, K.,
Tadano, T.,
Kitamura, K.,
and Kisara, K.
(2001)
Eur. J. Pharmacol.
419,
175-181[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Malmberg, A. B.,
and Yaksh, T. L.
(1994)
J. Neurosci.
14,
4882-4890[Abstract]
|
| 41.
|
Moreno, H.,
Rudy, B.,
and Llinas, R.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14042-14047[Abstract/Free Full Text]
|
| 42.
|
Wilson, S. G.,
and Mogil, J. S.
(2001)
Behav. Brain. Res.
125,
65-73[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Honoré, P.,
Menning, P. M.,
Rogers, S. D.,
Nichols, M. L.,
Basbaum, A. I.,
Besson, J. M.,
and Mantyh, P. W.
(1999)
J. Neurosci.
19,
7670-7678[Abstract/Free Full Text]
|
| 44.
|
Hunt, S. P.,
and Mantyh, P. W.
(2001)
Nat. Rev. Neurosci.
2,
83-91[Medline]
[Order article via Infotrieve]
|
| 45.
|
Herrero, J. F.,
Laird, J. M.,
and Lopez-Garcia, J. A.
(2000)
Prog. Neurobiol.
61,
169-203[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Murakami, M.,
Suzuki, T.,
Nakagawasai, O.,
Murakami, H.,
Murakami, S.,
Esashi, A.,
Taniguchi, R.,
Yanagisawa, T.,
Tan-No, K.,
Miyoshi, I.,
Sasano, H.,
and Tadano, T.
(2001)
Brain Res.
903,
231-236[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Scroggs, R. S.,
and Fox, A. P.
(1992)
J. Physiol. (Lond)
445,
639-658[Abstract/Free Full Text]
|
| 48.
|
Diochot, S.,
Richard, S.,
and Valmier, J.
(1995)
Neuroscience
69,
627-641[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Berrow, N. S.,
Campbell, V.,
Fitzgerald, E. M.,
Brickley, K.,
and Dolphin, A. C.
(1995)
J. Physiol. (Lond)
482,
481-491[Abstract/Free Full Text]
|
| 50.
|
Lambert, R. C.,
Maulet, Y.,
Mouton, J.,
Beattie, R.,
Volsen, S., De,
Waard, M.,
and Feltz, A.
(1997)
J. Neurosci.
17,
6621-6628[Abstract/Free Full Text]
|
| 51.
|
Dunlap, K.,
and Fischbach, G. D.
(1981)
J. Physiol. (Lond)
317,
519-535[Abstract/Free Full Text]
|
| 52.
|
Scott, R. H.,
and Dolphin, A. C.
(1986)
Neurosci. Lett
69,
59-64[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Ikeda, S. R.
(1996)
Nature
380,
255-258[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Zamponi, G. W.,
and Snutch, T. P.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
4035-4039[Abstract/Free Full Text]
|
| 55.
|
Feng, Z.-P.,
Arnot, M. I.,
Doering, C. J.,
and Zamponi, G. W.
(2001)
J. Biol. Chem.
48,
45051-45058
|
| 56.
|
Yu, C.,
Lin, P. X.,
Fitzgerald, S.,
and Nelson, P.
(1992)
J. Neurophysiol.
67,
561-575[Abstract/Free Full Text]
|
| 57.
|
Gruner, W.,
and Silva, L. R.
(1994)
J. Neurosci.
14,
2800-2808[Abstract]
|
| 58.
|
Miranda, H. F.,
Bustamante, D.,
Kramer, V.,
Pelissier, T.,
Saavedra, H.,
Paeile, C.,
Fernandez, E.,
and Pinardi, G.
(1992)
Eur. J. Pharmacol.
217,
137-141[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Seisenberger, C.,
Specht, V.,
Welling, A.,
Platzer, J.,
Pfeifer, A.,
Kuhbandner, S.,
Striessnig, J.,
Klugbauer, N.,
Feil, R.,
and Hofmann, F.
(2000)
J. Biol. Chem.
275,
39193-39199[Abstract/Free Full Text]
|
| 60.
|
Jun, K.,
Piedras-Renteria, E. S.,
Smith, S. M.,
Wheeler, D. B.,
Lee, S. B.,
Lee, T. G.,
Chin, H.,
Adams, M. E.,
Scheller, R. H.,
Tsien, R. W.,
and Shin, H. S.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
15245-15250[Abstract/Free Full Text]
|
| 61.
|
Saegusa, H.,
Kurihara, T.,
Zong, S,
Minowa, O.,
Kazuno, A.,
Han, W.,
Matsuda, Y.,
Yamanaka, H.,
Osanai, M.,
Noda, T.,
and Tanabe, T.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
6132-6137[Abstract/Free Full Text]
|
| 62.
|
Luo, Z. D.,
Chaplan, S. R.,
Higuera, E. S.,
Sorkin, L. S.,
Stauderman, K. A.,
Williams, M. E.,
and Yaksh, T. L.
(2001)
J. Neurosci.
21,
1868-1875[Abstract/Free Full Text]
|
| 63.
|
Cox, B.
(2000)
Curr. Rev. Pain.
4,
488-498[Medline]
[Order article via Infotrieve]
|
| 64.
|
Rice, A. S.,
and Maton, S.
(2001)
Pain
94,
215-224[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Murakami, T. Ohba, F. Xu, E. Satoh, I. Miyoshi, T. Suzuki, Y. Takahashi, E. Takahashi, H. Watanabe, K. Ono, et al.
Modified Sympathetic Nerve System Activity with Overexpression of the Voltage-dependent Calcium Channel {beta}3 Subunit
J. Biol. Chem.,
September 5, 2008;
283(36):
24554 - 24560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Jeon, I. Song, W. Guido, K. Kim, E. Kim, U. Oh, and H.-S. Shin
Ablation of Ca2+ Channel {beta}3 Subunit Leads to Enhanced N-Methyl-D-aspartate Receptor-dependent Long Term Potentiation and Improved Long Term Memory
J. Biol. Chem.,
May 2, 2008;
283(18):
12093 - 12101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Field, P. J. Cox, E. Stott, H. Melrose, J. Offord, T.-Z. Su, S. Bramwell, L. Corradini, S. England, J. Winks, et al.
Identification of the {alpha}2-{delta}-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin
PNAS,
November 14, 2006;
103(46):
17537 - 17542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Badou, M. K. Jha, D. Matza, W. Z. Mehal, M. Freichel, V. Flockerzi, and R. A. Flavell
Critical role for the beta regulatory subunits of Cav channels in T lymphocyte function
PNAS,
October 17, 2006;
103(42):
15529 - 15534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Weissgerber, B. Held, W. Bloch, L. Kaestner, K. R. Chien, B. K. Fleischmann, P. Lipp, V. Flockerzi, and M. Freichel
Reduced Cardiac L-Type Ca2+ Current in Cav{beta}2-/- Embryos Impairs Cardiac Development and Contraction With Secondary Defects in Vascular Maturation
Circ. Res.,
September 29, 2006;
99(7):
749 - 757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yasuda, R. J. Lewis, and D. J. Adams
Overexpressed Cav{beta}3 Inhibits N-type (Cav2.2) Calcium Channel Currents through a Hyperpolarizing Shift of "Ultra-slow" and "Closed-state" Inactivation
J. Gen. Physiol.,
March 29, 2004;
123(4):
401 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Murakami, H. Yamamura, T. Suzuki, M.-G. Kang, S. Ohya, A. Murakami, I. Miyoshi, H. Sasano, K. Muraki, T. Hano, et al.
Modified Cardiovascular L-type Channels in Mice Lacking the Voltage-dependent Ca2+ Channel {beta}3 Subunit
J. Biol. Chem.,
October 31, 2003;
278(44):
43261 - 43267.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|